Midwest Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Midwest Trust's BMY Position: Q1 2026 in Review
Midwest Trust reduced its Bristol-Myers Squibb (BMY) stake by 3.4% in Q1 2026, selling an estimated $239K and leaving 116,266 shares worth $7.05M. The position accounts for 0.09% of the portfolio, ranked #180.
Midwest Trust first reported a position in BMY in Q2 2025 and has held it in 4 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Midwest Trust held 116,266 shares of Bristol-Myers Squibb worth $7.05M as of Q1 2026.
- Midwest Trust sold 4,106 Bristol-Myers Squibb shares in Q1 2026, an estimated $239K.
- Bristol-Myers Squibb made up 0.09% of Midwest Trust's portfolio in Q1 2026, its #180 holding.
- Midwest Trust first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 4 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Midwest Trust's 13F filing for Q1 2026, filed 1 May 2026.